Akihiro Kume

Sakai Municipal Hospital — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index5.2kcitations222works15.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(91), RNA Interference and Gene Delivery(44), CAR-T cell therapy research(32), CRISPR and Genetic Engineering(28), Viral Infectious Diseases and Gene Expression in Insects(25)

Publications222 total

Reduction of Masseter Muscle Prominence (MMP) After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period 1 in Japan
Toxicon·2026
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years
British Journal of Dermatology·2024· 16 citedOpen Access
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial
British Journal of Dermatology·2024· 30 citedOpen Access
PB0183 Efficient Gene Transduction in Pigs and Macaques with the Engineered AAV Vector AAV.GT5 for Hemophilia B Gene Therapy
Research and Practice in Thrombosis and Haemostasis·2023Open Access
Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
Molecular Therapy — Methods & Clinical Development·2023· 9 citedOpen Access
Efficacy and safety of nemolizumab in paediatric patients aged 6–12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study
British Journal of Dermatology·2023· 40 citedOpen Access
Data from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 3 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure Legends 1-4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure Legends 1-4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 2 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 1 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Materials and Methods from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 2 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 3 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Materials and Methods from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 1 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Supplementary Figure 4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
Data from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Hiroaki Mizukami(34), Keiya Ozawa(31), Masashi Urabe(24), Takashi Okada(22), Yutaka Hanazono(10), Shin‐ichi Muramatsu(9), Ryosuke Uchibori(9), Tatsuya Nomoto(9), Imaharu Nakano(7), Takashi Matsushita(7), Kunihiko Ikeguchi(6), Takayuki Ito(6), Toshiharu Nagatsu(5), Kuniko Shimazaki(5), Mutsuko Nonaka‐Sarukawa(5), K Ozawa(5), Lijun Wang(4), Masafumi Takahashi(4), Yuhe Liu(4), Keiichi Ichimura(4)